SCOPE 2025: Spotlight on clinical trial technology
By Clara Rodriguez Fernandez
Johnson & Johnson acquires Intra-Cellular for $14.6bn
Transforming research through patient-centric design and innovation
Scope Summit finalists to fight for awards in site innovation and...
Verdiva Bio launches with $411m in funding to advance obesity drugs
India’s Anthem Biosciences plans $397m IPO
Orbis Medicines bags €90 million Series A to develop oral...
→
Insight
Verdiva Bio launches with $411m in funding to advance obesity drugs
→
→
→